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Although 1,1,1-trichloroethane will be phased out o f use by 1996, it will remain an 
environmental concern. Its wide use as a solvent in industry and for consumer 
products has resulted in large amounts being released to the environment. In 
addition, about 20% o f the approximately 1200 hazardous waste sites on the 
National Priorities List contain this chemical.
For the general population, the most likely sources o f exposure to 1,1,1- 
trichloroethane are home consumer products, building products, and contaminated 
food and water.
Inhalation abuse of 1,1,1-trichloroethane can result in "sudden sniffing death.”
This monograph is one in a series of self-instructional publications designed to increase the primary care 
provider's knowledge of hazardous substances in the environment and to aid in the evaluation of potentially 
exposed patients. See page 17 for more information about continuing medical education credits and continuing 
education units.
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How to use this issue...
This issue begins with a composite case study that describes a realistic encounter with a patient. This description 
is followed by a pretest. The case study is further developed through Challenge questions at the end of each 
section. To fully benefit from this monograph, readers are urged to answer each question when it is presented. 
(Answers to the Pretest and Challenge questions are found on pages 15-16.) The monograph ends with a posttest, 
which can be submitted to the Agency for Toxic Substances and Disease Registry (ATSDR) for continuing medical 
education (CME) credit or continuing education units (CEU). See page 17 for further instructions on how to receive 
these credits.
The objectives of this monograph on 1,1,1-trichloroethane are to help you
□  Explain why 1,1,1-trichloroethane may be an acute and chronic health hazard
□  Describe the factors that may contribute to 1,1,1-trichloroethane poisoning
□  identify potential environmental and occupational sources of exposure to
1.1.1-trichloroethane
□  Identify evaluation and treatment protocols for persons exposed to
1.1.1-trichloroethane
□  List sources of information on 1,1,1-trichloroethane
This issue is prepared with the assistance of those who share a common concern for physician education, public 
health, and the environment, including the following organizations: American Academy of Clinical Toxicology 
(AACT), American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American 
College of Emergency Physicians (ACEP), American College of Occupational and Environmental Medicine 
(ACOEM), American Medical Association (AMA), Association of State and Territorial Health Officials (ASTHO), 
and the Society of Teachers of Family Medicine (STFM). Final responsibility for the contents and views expressed 
in this monograph resides with ATSDR.
Agency for Toxic Substances and Disease Registry 
Project Officers: Max Lum, EdD; Donna Orti, MS; and Patricia Poindexter, MPH 
Edited by Teresa Ramsey, MA 
Prepared by DeLima Associates, San Rafael, California, 
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1,1,1,-Trichloroethane
A mother who attributes her daughter’s congenital heart defect to air pollution
Your practice is located in a valley with a number of computer-related, high-technology, “smokeless” industries. One of 
your patients, a young mother whose 8-month-old daughter was born with a congenital heart defect, comes to your office to 
discuss a recent newspaper article that suggests toxic chemicals may cause birth defects. After reading the article, she 
discovered that two of her neighbors had miscarriages shortly before her daughter’s birth, two neighbors had recently given 
birth to babies who have defects, and one neighbor had a stillbirth. Many of the neighbors spoke of often smelling a sweet, 
solvent-like odor in the outdoor air.
Your patient is determined to confirm her suspicion that a chemical in the air from the local computer chip manufacturing 
plant is responsible for these events. She has called the city council and is not satisfied that she will get a prompt hearing. She 
has organized a small group of concerned citizens. She asks you to be a consultant to the group and provide medical 
information at the group’s first meeting.
Your patient gives you a list of chemicals that she has determined are or have been used at the plant. The list includes 
arslne, phosphine, trichloroethylene, 1,1,1 -trichloroethane, tetrachloroethylene, epoxy resins and curing agents, hydrofluoric 
acid, and gallium arsenide. You know that arsine, phosphine, and hydrofluoric acid are quite toxic and used in relatively small 
quantities in the electronics industry. Emissions are unlikely to escape the plant daily. In addition, the odors of these chemicals 
do not fit the patient’s description. The epoxy resins and gallium arsenide are not volatile substances and are not likely to be 
detected outside the plant. You conclude that the chemicals most likely to be emitted in large quantities are the solvents.
You contact the regional office of the Environmental Protection Agency (EPA) for information on processes used by 
computer chip manufacturers and the quantities of solvents that might be involved. The environmental specialist searches the 
Toxic Chemical Release Inventory (TRI) database and informs you that the plant in question is a major emitter of 1,1,1- 
trichloroethane (TCA); last year, it emitted more than 100,000 pounds of the chemical. The specialist informs you that the plant 
does not emit significant quantities of the other chemicals on your list. You focus on the cluster of cases and the TCA exposure.
‘P re te s u J ^ ^
(a) What are the major health effects caused by 1,1,1-trichloroethane?
(b) Is 1,1,1 -trichloroethane likely to be responsible forthe congenital heart defect of your patient’s daughter?
(c) What is the Toxic Chemical Release Inventory database that was used by the specialist?
(d) What sources will you use to prepare for the community group meeting? What will you advise?
Answers to the Pretest questions are on page 15.
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Exposure Pathways
□  More than 700 million pounds 
of TCA are produced in the 
United States annually.
□  For the general population, 
exposure occurs most often 
through the many home 
products containing TCA.
□  Airtight, highly insulated 
homes enhance 
accumulation of indoor TCA 
levels.
1.1.1 -Trichloroethane (CI3CCH3) is not known to occur naturally. Origi­
nally produced as a safer replacement for carbon tetrachloride and later 
for trichloroethylene, it has become ubiquitous in the environment.
1,1,1-Trichloroethane is a nonflammable, colorless liquid that evapo­
rates quickly at room temperature. It has a sweet, somewhat sharp odor 
that can be detected at about 100 parts per million (ppm). (This odor 
threshold is below the permissible exposure limit [PEL] for the work­
place of 350 ppm.)
1.1.1 -Trichloroethane is commonly referred to as TCA (used throughout 
this document). Synonyms for TCA include methyl chloroform, 
chloroethene, methyltrichloromethane, trichloromethylmethane, alpha- 
trichloroethane, and alpha-T. TCA should not be confused with TCE, 
which commonly refers to trichloroethylene (CI2C=CHCI).
The general population is exposed to TCA through ambient air, contami­
nated water, or by using household or office products containing the 
chemical. TCA is found in many building materials, including carpet 
glues and fabric finishers. The trend toward airtight, highly insulated 
houses has resulted in higher concentrations indoors than outdoors. In 
one study, average TCA air levels were about 4 ppb indoors and less 
than 1 part per billion (ppb) outdoors. Volatilization of TCA from 
contaminated water during showering, laundering, and other activities 
can add substantially to indoor exposure.
In a recent EPA study of household products, nearly 250 consumer 
items contained TCA. Some of these items include the following: fabric 
water repellants, spot removers, spray shoe polishes, spray paints, 
paint thinners and removers, pesticides, lubricants for auto door locks, 
tape and video recorder head cleaners, electric shaver cleaners, and 
typewriter correction fluids. Some correction fluids and thinners that 
have high concentrations of TCA are widely abused through inhalation 
for their narcotic effects. Deaths have resulted from this exposure route 
despite the mustard oil added to these products to discourage abuse, 
and some states have banned TCA use in correction fluids and thinners. 
TCA is also used as a propellant and solvent carrier in some aerosolized 
bronchodilators. In the past, TCA was used as an anesthetic. In 1990, 
705 million pounds of TCA were produced in the United States.
TCA is released to the environment by stack and fugitive emissions and 
in wastewater from the numerous industries that produce or use this 
compound. It is used in more than 120 industrial classifications (includ­
ing the defense and electronics industries), primarily as a solvent, vapor 
degreaser, cold metal cleaner, and propellant. Releases to surface 
water evaporate quickly, and spills on land dissipate readily through 
volatilization and leaching. The half-life of TCA in surface water ranges 
from hours to a few weeks, depending on wind and water turbulence. 
Bioaccumulation does not occur to a significant degree.
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In soil, TCA undergoes slow degradation, and because it is not 
strongly adsorbed to sandy or clay soils, it can readily leach to 
underground aquifers. Amounts of TCA in groundwater vary widely 
by location. In one study of groundwater in 13 U.S. cities, EPA found 
23% of the sources contained TCA (maximum concentration 13 
micrograms per liter [fxg/L] [13 ppb]). Groundwater samples taken 
near sources of release have been as high as 11,000 ppb.
TCA released to air is transported long distances and will partially 
return to earth in rain. In the troposphere, TCA degrades very slowly 
by photooxidation; the half-life is 6 months to 25 years, depending on 
the intensity of sunlight. Due to the large input of TCA into the 
atmosphere and its slow degradation, the amount of TCA in ambient 
air is increasing by 12% to 17% annually. TCA slowly diffuses to the 
stratosphere where photodegradation is rapid, and the chlorine free 
radicals that are generated contribute to the destruction of the ozone 
layer. In 1992, the 93 signatories to the Montreal Protocol, an 
international agreement to control ozone-depleting substances, agreed 
to ban TCA and certain other chlorocarbons by 1996,4 years earlier 
than previously agreed.
* Use of trade names is for identification only and does not imply endorsement 
by the Public Health Service or the U.S. Department of Health and Human 
Services.
Additional information for the case study: In a discussion with the environmental engineer at the plant, 
you learn that within the last 6 months the plant has installed control measures to reduce emissions and 
is switching to aqueous-based degreasing agents and ultrasonic technology in their cleaning and 
degreasing processes. He predicts very little will be emitted from the plant in the near future.




□  Workers involved in
operations using TCA are at 
greatest risk of exposure.
□  Persons who inhale TCA 
intentionally for its narcotic 
properties risk “sudden 
sniffing death.”
According to a study conducted by the National Institute for Occupa­
tional Safety and Health (NIOSH), more than 1.5 million workers are 
potentially exposed to TCA. Workers with the greatest potential for 
exposure to TCA are in the following industries or operations:
auto repair
computer chip manufacture 
degreasing and cleaning of metal parts 
dry cleaning
electrical parts manufacture
heating and cooling parts during manufacture
mixing and applying commercial resins
photography
solvent recovery
spray painting and gluing
typesetting
waste disposal
The general population is at risk of exposure through the use of home 
products that contain TCA, but the levels of exposure associated with 
normal use have not been shown to cause adverse health effects. 
Intentional inhalation of TCA for its narcotic effects is a problem, 
however, and is most common among adolescents. Persons who 
deliberately sniff glue or solvents to achieve euphoria risk adverse 
health effects, such as “sudden sniffing death" from cardiac 
dysrhythmias.
Persons living in homes that use a TCA-contaminated water source 
risk exposure through ingestion of tapwater, inhalation of volatilized 
TCA, and dermal contact during showering and laundering. Persons 
who live near point sources of TCA or near waste disposal sites also 
risk exposure to above-background levels.
Persons who have histories of alcoholism or severe underlying liver 
disease may be at increased risk of TCA’s adverse effects. Alcohol 
competitively inhibits the metabolism of TCA. Alcohol and severe liver 
disease could prolong TCA metabolism and its effects on the central 
nervous system (CNS).
1,1,1 - Trichloroethane Toxicity
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Additional information for the case study: As a result of your work with the community group, you receive 
a call from a reporter. A wire story indicates that a consumer group had hired a laboratory to test 
disposable baby diapers and found TCA at 20 ppb in one brand of diapers. The reporter asks whether 
he should run the story, warning parents that these diapers might have adverse health effects on their 
babies and challenging grocers to pull the brand from their shelves.
(2) What is your response to the reporter’s question?
Biologic Fate
TCA is absorbed efficiently and rapidly through the lungs and gas­
trointestinal tract and less rapidly through the skin. Steady-state lung 
retention of 25% to 30% of inhaled TCA in humans is reached within 
1 to 3 hours of continuous exposure. Continuous exposure also results 
in a gradual rise and plateau of arterial and venous blood levels. 
Increases in pulmonary ventilation or respiratory rate during exercise 
are not believed to affect changes in the absorbed quantity of TCA 
after steady-state levels are reached.
TCA is absorbed efficiently by all 
routes of exposure.
TCA is lipophilic and accumulates to a small extent in the body fat. The 
largest amount of TCA is found in brain tissue, although tissue 
concentrations throughout the body vary widely. Blood levels corre­
late highly with levels found in alveolar air. A much greater amount of 
TCA is absorbed during inhalation exposure than during skin contact.
Regardless of its route of 
absorption, most TCA is excreted 
unchanged through the lungs.
Regardless of the route of absorption, most TCA (e.g., about 90% of 
an inhaled dose) is quickly excreted unchanged by the lungs. It has a 
half-life for elimination from the blood of approximately 53 hours; small 
amounts of TCA have been detected in the breath several days after 
exposure has ceased. The remaining 10% of an inhaled dose is 
excreted unchanged in the urine or metabolized by hepatic cyto­
chrome P-450 mixed-function oxidase enzymes to trichloroethanol 
and then to trichloroacetic acid. These metabolites can be detected in 
blood and urine. The half-life of trichloroethanol, which is excreted in 
urine, is about 9 hours. Because trichloroacetic acid binds to serum 
albumin, this metabolite persists in the bloodstream with a half-life of 
about 3 days.
A small amount of TCA is 
metabolized in the liver.
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Additional information for the case study: Community concern about TCA prompts another patient to 
call you. He and his wife think their adolescent son is abusing TCA and want you to run some tests to 
con firm this.
(3) What is your response ?
Physiologic Effects
□  Primarily the central
nervous, cardiovascular, and 
respiratory systems are 
affected by acute TCA 
exposure.
Fatalities following exposure to anesthetic concentrations of TCA have 
usually been due to CNS depression, resulting in respiratory arrest. 
Cardiac dysrhythmias may also occur after exposure to high levels, 
especially in solvent abusers. Ingestion of TCA may cause immediate 
burning of the mouth, throat, and esophagus; nausea, vomiting, and 
diarrhea occur after large ingestions. Because of TCA’s defatting 
action, local skin irritation, erythema, vésiculations, and dermatitis can 
occur after repeated contact. Stabilizing agents added to TCA, such as 
epichlorohydrin and dioxane, are sensitizers and may be responsible 
for some of TCA’s dermatologie effects. TCA contact with unprotected 
eyes can produce transient and superficial tissue effects, including 
chemosis, hyperemia, and conjunctivitis.
Neurologic Effects
□  The principal effect of TCA 
exposure is CNS depression.
With increasing concentration of TCA, CNS depression and euphoric 
narcosis occur in proportion to the amount of TCA absorbed. Mild motor 
impairment is followed by stupor, coma, and seizures. In acute, high- 
level exposures, the anesthetic effect occurs rapidly. With chronic 
exposure, a consistent finding is agitation or lethargy during sedentary 
periods. Decreased memory and sleep disturbances have also been 
reported from chronic, low-level exposure.
TCA is lipophilic and accumulates in the central nervous system, 
resulting in respiratory depression. This depression is mediated, in 
part, by effects in the brain stem, as well as by generalized CNS 
narcosis.
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Cardiovascular Effects
Acute or chronic exposures to high concentrations of TCA may cause 
reduced blood pressure and dysrythmias. Sudden death can occur in 
chronic abusers who inhale TCA. One study suggests that sudden 
sniffing death from TCA may result from light-plane anesthesia in 
combination with acute respiratory depression from a medullary 
chemical lesion. Others suggest that death may be due to a fatal 
dysrhythmia caused by lowering the myocardial threshold to the 
effects of epinephrine or other catecholamines.
Tachycardia noted in exposures to low doses and bradycardia ob­
served in exposures to high doses may be controlled by the sympa­
thetic nervous system. If dysrhythmias resolve spontaneously or by 
treatment, usually no permanent or recurrent problem occurs; how­
ever, bouts of premature ventricular contractions, including bigeminy, 
have been reported to reoccur within 1 to 2 weeks.
Respiratory Effects
TCA has a direct irritating effect on the nasal and respiratory mucous 
membranes. Although this irritant effect is moderate with pure TCA, it 
can be more severe with technical grade TCA that is stabilized with 
dioxane or epichlorohydrin. Shortness of breath and chest pain can 
occur. Acute, high-level exposures to TCA may result in CNS- 
mediated respiratory depression.
Hepatic and Renal Effects
Hepatic and renal dysfunction can occur 1 to 2 days after a single 
acute exposure to TCA, as evidenced by abnormal liver function and 
hepatic lesions. In one study, mild and transient elevation of liver 
function tests occurred in 33% of workers acutely exposed to high 
concentrations of TCA. Liver enzymes are often elevated on the first 
day after exposure, with bilirubin typically rising on the second day. 
Transient renal damage may also occur as initially evidenced by 
hematuria and proteinuria. These abnormal test results usually sub­
side within a few days to 1 week, except in persons who have chronic 
exposures.
Developmental and Reproductive Effects
No data are available on the reproductive or developmental effects of 
TCA in humans. A multigeneration reproductive study of rats exposed 
to TCA in drinking water found no reproductive effects. Only one 
inhalation study found evidence of minor embryotoxicity in experimen­
tal animals. No human studies have been reported.
□  Cardiac dysrhythmias may result 
from lowering of the myocardial 
threshold to the dysrhythmogenic 
effects of epinephrine.
□  Respiratory depression associated 
with TCA exposure is 
secondary to CNS depression.
□  Hepatic and renal dysfunction may 
occur within 1 to 2 days after TCA 
exposure.
□  No data exist to assess the 
reproductive and developmental 
effects of TCA in humans.
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No evidence has been 
reported that suggests TCA is 
carcinogenic in humans or 
experimental animals.
Carcinogenic Effects
TCA does not appear to be carcinogenic in humans or experimental 
animals, although the data in humans are limited.
C fia tteng t^r
Additional information for the case study: The story of your patient and her activities receives national 
attention. You receive a call from a young woman in another state who has been diagnosed with multiple 
sclerosis. She had been a secretary for 5 years and used correctional fluids and thinners extensively. 
She read in the newspaper that these materials contain TCA, as do many household products, and that 
TCA can cause neurologic effects. She asks you whether TCA could be the cause of her condition.
(4) How will you respond to this question?
Clinical Evaluation
History and Physical Examination
□  A thorough work and A careful history should first be obtained from the person with suspected
exposure history is exposure, unless life-threatening circumstances exist. Even if serious
essential to correctly conditions require immediate treatment, the patient should be ques-
diagnosing TCA toxicity. tioned while medical care is being given. Family members orfriends, as
well as emergency medical response personnel, may also be able to 
provide valuable information regarding exposure.
If the exposure occurred in the workplace, identification of the sub­
stance to which the patient was exposed should be verified, if possible, 
from the container label or a Material Safety Data Sheet (MSDS) or by 
calling the workplace supervisor. A regional poison control center can 
help determine ingredients of brand name products and treatment for 
patients who have been exposed.
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Especially in cases of chronic exposure, TCA exposure from all 
sources must be assessed. These sources include the following: use 
of TCA-containing household products, nearby industries, a recently 
remodeled or constructed home, diet, water supply, workplace, hob­
bies such as furniture refinishing, and recreational activities involving 
machinery or vehicles. If an airborne exposure is involved, the time the 
odors were detected and the time of onset of symptoms and their 
sequence are important. However, the presence of an odor does not 
necessarily mean that toxic effects will occur because the TCA air 
level that causes adverse health effects is substantially above the 
odor threshold. The relative ventilation and amount of TCA vaporized 
compared to the air volume of the room are important.
After addressing the patient’s initial complaints, the physical examina­
tion should emphasize the organ systems most likely to be affected by 
TCA—cardiovascular, pulmonary, central nervous, and gastrointesti­
nal (if ingestion of TCA occurred). Evaluation of the renal and hepatic 
systems should be assessed through laboratory testing. The patient 
should be questioned about intercurrent illness and medications, 
which may compromise the patient’s response to toxic exposure.
Signs and Symptoms
Initial symptoms of TCA toxicity include headache, dizziness, fatigue, □  Initial symptoms of overexposure
sleepiness, and nausea. Ataxia, confusion, and stupor can occur with to TCA are neurologic.
acute exposure. Underlying disorders of the heart and lungs may be
exacerbated by TCA exposure. Gastrointestinal signs usually do not
proceed beyond nausea in cases of inhalation exposure. Ingestion of
TCA may cause vomiting.
Chronic exposure to levels greater than 350 ppm may result in mild 
headaches, short-term memory loss, sleep disturbances, and ataxia.
The patient should be questioned about other exposures that could be 
contributory including alcohol and drug abuse, prescription drugs, and 




Most of the TCA absorbed by the body is excreted unchanged by the □  Generally, only reference
lungs. About 60%  to 80% of an absorbed dose is excreted in 1 week, laboratories perform tests for TCA
but TCA can be detected in breath weeks after exposure. TCA has an blood and breath levels.
elimination half-life in blood of about 53 hours. TCA blood and breath





□  TCA metabolites can be
measured in blood and urine.
The metabolites of TCA, trichloroethanol and trichloroacetic acid, can 
be detected in blood and urine. Trichloroacetic acid binds to serum
albumin and will persist in the blood with a half-life of about 3 days. 
These metabolites can be detected in the urine for a few days after mild 
exposures and a few weeks after heavy exposures. TCA metabolite 
measurements are useful if they are markedly elevated compared with 
normal background levels and if exposure to trichloroethylene, chloro­
form, and chloral hydrate (which produce the same metabolites) can be 
excluded.
Mild elevations of liver function tests, such as hepatic transaminases 
(SGOT or AST, SGPT or ALT), can occur after acute exposures but are 
usually mild; they most often return to normal after several days. Total 
bilirubin may also increase. Transient proteinuria and microscopic 
hematuria are sometimes accompanied by an increase in BUN or 
serum creatinine.
Additional information for the case study: A neighbor o f the patient in the case study is an 
employee at an airline maintenance depot. He has been taking TCA home from work to use 
as a cleaner for many household chores. His wife, who used it for carpet cleaning, broke out 
with hives. The condition cleared when her physician prescribed prednisone in tapered doses. 
The next time she used the TCA, however, the hives returned and became much worse, 
developing into large confluent splotches. She had had hives several years before when 
working in a photo lab.
(5) Is TCA the cause of this skin condition? Explain.
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Treatment and Management
There are no antidotes for TCA toxicity. Patients should be removed 
from the contaminated environment as soon as possible, with priority 
given to ventilatory support, if needed. Supplemental oxygen should be 
initiated if respiration, pulse, blood pressure, or mental status is 
compromised. Continuous cardiac monitoring should be maintained 
until stability is established. Hemodialysis and hemoperf usion have not 
been proven efficacious.
Contaminated clothing and personal items should be removed and 
double-bagged. Skin should be washed with mild soap or detergent 
and copious water. Care should be taken to avoid secondary contami­
nation of health care personnel from off-gassing vapors or vomitus.
If TCA is splashed in the eye, the eye should be irrigated with water for 
15 minutes. If the splash was more than transient, the corneal surface 
should be stained with fluorescein and examined using a slit lamp. 
Applying a protective lubricating antibiotic ointment and eye patch 
usually will enable the cornea to re-form epithelium within 24 to 48 
hours.
If TCA is ingested, emesis is not advised because of possible pulmo­
nary aspiration. Gut decontamination with lavage and activated char­
coal is recommended if the procedure can be initiated within 2 to 3 
hours after ingestion of more than a single swallow of TCA. Protect the 
airway to prevent pulmonary aspiration. Electrolyte balance should be 
maintained, and hepatic and renal dysfunction should be monitored 
until normal.
Chronic exposure to TCA is treated symptomatically. Hepatic and 
renal function should be assessed. If the exposure was occupational, 
periodic workplace air monitoring should be carried out to ensure 
compliance with regulations of the Occupational Safety and Health 
Administration (OSHA).
□  Supportive care and removal from 
the source of exposure are 





Additional information for the case study: Testing of private wells in the vicinity of the plant reveals TCA 
contamination ranging from 30 to 2321xg/L (ppb). (EPA has a standard of 200 ppb in public drinking 
water supplies.)
(6) Do you expect these residents to manifest symptoms of exposure? What management and 




OSHA regulations are based on protecting healthy workers from 
significant exposure to chemical hazards over a 40-hour workweek. 
The 1989 permissible exposure limit (PEL) for TCA as an 8-hour time- 
weighted average (TWA) was set at 350 ppm. The American Confer­
ence of Governmental Industrial Hygienists (ACGIH) recommends a 
threshold limit value (TLV) of 350 ppm. ACGIH also recommends a 
short-term exposure limit (STEL) of 450 ppm. NIOSH recommends 
that occupational exposures to TCA be controlled so that workers are 
not exposed to levels greater than 350 ppm (ceiling concentration) as 
determined by a 15-minute sample (Table 1).
ACGIH has also set guidelines (Biological Exposure Indices [BEI]) for 
the amount of TCA metabolites in urine of exposed workers. For 
trichloroethanol, the BEI is 30 milligrams/liter (mg/L) in urine samples 
obtained at the end of the workweek, and for trichloroacetic acid, the 
BEI is 10 mg/L.
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Table 1. Standards and regulations for 1,1,1-trichloroethane
Agency* Focus Level Comments


















‘ ACGIH = American Conference of Governmental Industrial Hygienists; EPA = Environmental Protection Agency; NIOSH = National Institute for 
Occupational Safety and Health; OSHA = Occupational Safety and Health Administration
tTLV-TWA (threshold limit value-time-weighted average) = time-weighted average concentration for a normal workday and a 40-hour workweek 
to which nearly all workers may be repeatedly exposed without adverse effects.
§IDLH (immediately dangerous to life and health) = represents the maximum concentration from which, in the event of respirator failure, one could 
escape within 30 minutes without a respirator and without experiencing any escape-impairing (e.g., severe eye irritation) or irreversible health 
effects.




EPA has set a standard of 200 ng/L (200 ppb) of TCA for drinking 
water. To protect fish and wildlife, EPA has set the ambient water level 
at 18 mg/L (18 ppm).
Air
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Protection Agency, Office of Toxic Substances, 1987. Report No. EPA-OTS 560/5-87-005.
Environmental Protection Agency. Household solvent products: a “she lf survey with laboratory analysis. Washington, DC: US 
Environmental Protection Agency, Office of Toxic Substances, 1987. Report No 560/5-87-006.
Sources of Information
More information on the adverse effects of 1,1,1-trichloroethane and treating cases of exposure to TCA can be 
obtained from ATSDR, your state and local health departments, and university medical centers. Case Studies in 
Environmental Medicine: 1,1,1 -Trichloroethane Toxicity is one of a series. To obtain other publications in this 
series, please use the orderform on the inside back cover. For clinical inquiries, contact ATSDR, Division of Health 
Education, Office of the Director, at (404) 639-6204.
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Answers to Pretest and Challenge Questions
Pretest questions are on page 1. Challenge questions begin on page 3.
Pretest
(a) Chronic, low-level TCA exposure produces primarily neurologic effects including agitation, lethargy, de­
creased memory, and sleep disturbances. Chronic abuse of TCA may cause cardiac dysrhythmias and central 
nervous system depression leading to respiratory arrest.
(b) There is no evidence in humans or animals that TCA causes congenital heart defects at any air level.
(c) The Toxic Chemical Release Inventory (TRI) is mandated by the federal government as part of community 
right-to-know legislation. I ndustries must report annually the chemicals they discharge to the environment and 
an estimate of the amounts. This information is incorporated into a database, which is organized by geographic 
location (state and county) and by chemical. Citizens may access TRI to determine the major sources of 
environmental release in their vicinity and the chemicals causing that pollution.
(d) Sources that will assist you in preparing for the group meeting are standard toxicology books, on-line 
databases, and journal articles. In addition, you could talk to persons at ATSDR, the state health department, 
EPA, the regional poison control center, the trade association for the electronics industry, and health and safety 
personnel at the plant.
At the meeting, you could discuss your findings, then tell the audience about the effects of TCA, pointing out 
areas where health data are incomplete or unavailable. You could explain that different levels of exposure to 
TCA can occur and include deliberate inhalation abuse (air concentrations in thousands of ppm), legal 
workplace levels (air concentrations to 350 ppm), and environmental levels (typically lower than workplace 
levels). Because some of the people could smell the solvent outdoors, one may assume the concentration was 
above 100 ppm, the odor threshold for TCA. However, EPA currently has no ambient air standard for TCA, 
so it is difficult to assess the risk. You could also explain to the audience that events such as birth defects or 
cancer could occur in random clusters.
There is no evidence that TCA causes heart defects. However, exposures to any source of TCA should be 
minimized, and you might discuss how exposures could occur. Your advice might be that the group express 
their concerns to officials at the plant and that they contact the local or state health department to request 
investigation of the problem through air and water measurements, air and water modeling, and further 
epidemiologic investigations.
Challenge
Challenge questions begin on page 3.
(1) TCA is in many household products as a degreaser, solvent, or propellant. Commonly used products are fabric 
water repellants, spot removers, spray shoe polishes, spray paints, and paint thlnners and removers. 
Household and office exposures can also occur from off-gassing of carpet and fabric drapes if the building is 
newly built or recently remodeled. TCA is in many aerosolized medications, such as bronchodilators. It is 
important to have adequate ventilation indoors, especially if any of these products are used in significant 
amounts or are spilled.
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It would not be unusual for the computer chip manufacturing plant to store TCA in underground storage tanks. 
Leaking storage tanks at electronics plants have been reported to contaminate groundwater in several areas. 
Testing the community’s water supply could help to determine whether leaking underground tanks are 
contributing to TCA exposure.
(2) You tell the reporter that he should not run the story and falsely alarm parents. You then attempt to put the 
information in perspective for the media representative. Under EPA rules, drinking water may contain up to 
200 (xg/L (200 ppb); bathing water may contain up to 18,000 ppb. You are not aware of a TCA standard for 
disposable diapers. While it is true that children are more susceptible to many toxicants and often exhibit signs 
of poisoning at lower levels than adults (e.g., lead or organophosphate pesticide exposures), the TCA level 
of 20 ppb is not cause for alarm. You further explain that TCA is one of the less hazardous solvents in terms 
of health effects. The level of TCA found is also not likely to cause diaper rashes, which occur in more than 
20% of infants in the first 6 months of life.
(3) The best test for confirmation of exposure is the measurement of TCA in the blood. If TCA is detected in the 
blood, the adolescent most likely inhaled it within the last 5 to 7 days. If TCA metabolites (trichloroethanol or 
trichloroacetic acid) are also detected in the same blood sample, he may be a chronic abuser. TCA is quickly 
exhaled from the lungs; therefore, TCA metabolites are not likely to be present after a one-time use.
An approach that requires biologic testing is a bit adversarial, however. Rather, both parents should educate 
their son about the hazards of inhalant abuse. They should get involved in closely monitoring their child’s 
activities. If school performance is deteriorating or they have other reasons to suspect their son’s activities, 
enrolling him in a community substance abuse program and enlisting the help of a mental health professional 
to explore why their son is taking such risks may be appropriate. Inhalation abuse of solvents is most common 
in adolescents, and many states have mandated restrictions on selling spray paints and solvents to juveniles.
(4) TC A exposure has not been associated with multiple sclerosis (MS). MS is the most common chronic disease 
of the central nervous system in young adults in North America. It is characterized by the occurrence of discrete 
areas of demyelination or plaques in the brain or spinal cord with symptoms including some degree of 
paralysis, nystagmus, and disturbances of speech, depending on the site of the lesions.
(5) Although degreasing or defatting skin of endogenous oils is the most common skin problem with TCA, contact 
dermatitis, hives, and urticaria have been reported, usually associated with a history of these conditions. 
These allergic conditions are associated with use of TCA in a stabilized form, which contains dioxane or 
epichlorohydrin. Both of these stabilizers are not only stronger irritants than TCA, but also skin sensitizers. 
(See Case Studies in Environmental Medicine: Skin Lesions and Environmental Exposures.)
(6) The appearance of symptoms will depend upon dose, duration, and route of exposure. The routes of exposure 
include ingestion of the contaminated water and inhalation and dermal exposure during showering, launder­
ing, or cleaning. The highest level found is not significantly above the EPA regulation. The mean daily intake 
of TCA from all sources (air, food, and water) has been determined to be between 50 and 1000 |xg/day; 
therefore, one would not expect symptoms in most people. Because children and elderly persons are generally 
more susceptible to toxic agents, households with these occupants could consider changing their source of 
water.
16
1,1,1 - Trichloroethane Toxicity
Posttest and Credits
Continuing education credit is available to health professionals who use this monograph and complete the 
posttest. The criterion for awarding continuing medical education (CME) credits and continuing education units 
(CEU) is a posttest score of 70% or better.
The Centers for Disease Control and Prevention (CDC) is accredited by the Accreditation Council for Continuing 
Medical Education (ACCME) to sponsor continuing medical education for physicians, and by the International 
Association for Continuing Education and Training (IACET) to sponsor continuing education units for other health 
professionals.
The Agency for Toxic Substances and Disease Registry, in joint sponsorship with CDC, is offering 1 hour of CME 
credit in Category 1 of the Physician's Recognition Award of the American Medical Association and 0.1 hour of 
CEU for other health professionals upon completion of this monograph.
In addition, the series Case Studies in Environmental Medicine has been reviewed and is acceptable for credit 
by the following organizations:
The American Academy of Family Physicians (AAFP). This program has been reviewed and is acceptable for 
1 prescribed hour by the American Academy of Family Physicians. (Term of Approval: beginning January 1992.) 
For specific information, please consult the AAFP Office of Continuing Medical Education.
The American College of Emergency Physicians (ACEP). Approved by the American College of Emergency 
Physicians for one hour per issue of ACEP Category I credit.
The American Osteopathic Association (AOA). AOA has approved this issue for 1 credit hour of Category 
2-B credit.
The American Association of Occupational Health Nurses (AAOHN). AAOHN has approved this program for 
1.0 contact hours. Applicant will receive the assigned code number in the award letter.
The American Board of Industrial Hygiene (ABIH). ABIH has approved this program for 0.5 certification 
maintenance (CM) point per three Case Studies. The CM approval number is 2817.
To receive continuing education credit (CME or CEU), complete the Posttest on page 18 in the manner shown in 
the sample question below. Circle all correct answers.






After you have finished the Posttest, please transfer your answers to the answer sheet on page 19 and complete 
the evaluation on the lower half of that page. Fold, staple, and mail the back cover to Continuing Education 
Coordinator, Agency for Toxic Substances and Disease Registry, Division of Health Education, E33,1600 Clifton 
Road, Atlanta, GA 30333. Your confidential test score will be returned with an indication of where the correct 
answers can be found in the text. Validation of earned CME credit and CEU will also be forwarded to participants, 




POSTTEST: 1,1,1 - TRICHLOROETHANE
Circle all correct answers. Record your answers on page 19.






2. Chronic exposure to TCA may
a. cause headaches
b. mildly alter liver function
c. cause short-term memory deficits
d. cause Alzheimer’s disease
e. cause early onset of symptoms from human immunodeficiency virus (HIV)
3. Laboratory tests to confirm TCA exposure might include
a. blood analysis for trichloroethanol
b. breath analysis for trichloracetic acid
c. urinary creatinine
d. cardiac isoenzymes
e. blood analysis for TCA
4. Clinical effects associated with acute exposure to pure TCA at concentrations greaterthan 1000 ppm include
a. unconsciousness or coma
b. cardiac arrhythmias
c. hematuria or proteinuria
d. mild liver dysfunction
e. stroke
5. Drinking water contaminated with low levels of TCA has been associated with
a. oral mucous membrane irritation
b. hepatorenal syndrome
c. children with cleft palates born to exposed women
d. no specific pathology
e. cancer
6. Cardiac toxicity due to TCA exposure
a. may lead to dysrhythmias
b. is caused by the metabolism of TCA to carbon dioxide
c. causes increased mortality among metal degreasers
d. is associated with inhalation abuse of TCA
e. is a frequent cause of death among dry-cleaning workers
7. Treatment for acute inhalation of TCA may include
a. symptomatic support




8. The likelihood of TCA exposure exists for
a. dry cleaners
b. auto mechanics
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CASE STUDIES IN ENVIRONMENTAL MEDICINE: 1,1,1 - TRICHLOROETHANE TOXICITY
If you wish CME credits or CEU, please indicate your answers to the Posttest questions on page 18 by circling 
the letters below for the correct answers. Complete the evaluation questionnaire and fill in the information 
requested on the reverse side. Tear off this last page, fold, staple, and mail to Continuing Education Coordinator, 
Agency for Toxic Substances and Disease Registry, Division of Health Education, E33, 1600 Clifton Road, 
Atlanta, GA 30333.
1. a b c d e
2. a b c d e
3. a b c d e
4. a b c d e
5. a b c d e
6. a b c d e
7. a b c d e
8. a b c d e
Evaluation Questionnaire
Please complete the following evaluation by putting a check in the appropriate box.
Yes No Undecided
1. As a result of completing this monograph, I will be able to:
Explain why 1,1,1-trichloroethane may be an acute and chronic health hazard. □ □ □
Describe the factors contributing to 1,1,1-trichloroethane toxicity. □ □ □
Identify potential environmental and occupational sources of 
exposure to 1,1,1-trichloroethane. □ □ □
Identify evaluation and treatment protocols for persons 
exposed to 1,1,1-trichloroethane. □ □ □
List sources of information on 1,1,1-trichloroethane. □ □ □
2. I am more likely to ask patients questions regarding possible environmental 
exposures as a result of reading this issue. □ □ □
3. I would recommend this issue to my colleagues. □ □ □
4. I will keep this issue as a reference. □ □ □
Comments:.
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□  CEU 
Specialty__
Zip
□  CME-AAFP □  CME-ACEP
I I Contact Hours - AAOHN
□  CME-AOA
□  CM-ABIH







Agency for Toxic Substances and Disease Registry 
Division of Health Education, E33 
1600 Clifton Road, NE 
Atlanta, GA 30333
fold here second
Please send me the following Case Studies in Environmental Medicine.
□ Arsenic □ Exposure History □ Radon
□ Asbestos □ Gasoline □ Risk Communication
□ Benzene □ Jet Fuel □ Reproductive and
□ Beryllium □ Lead Developmental Haze
□ Cadmium □ Mercury □ Skin Lesions
□ Carbon Tetrachloride □ Methanol □ Stoddard Solvent
□ Chlordane □ Methylene Chloride □ Tetrachloroethylene
□ Cholinesterase Inhibitors □ Nitrates/Nitrites □ 1,1,1-Trichloroethane
a Chromium a Pentachlorophenol a Trichloroethylene
□ Cyanide a Polyaromatic Hydrocarbons (PAHs) □ Toluene
□ Dioxins □ Polychlorinated Biphenyls (PCBs) a Vinyl Chloride
a Ethylene/Propylene Glycols □ Radiation
ML0993
staple or tape
C E N T E R S  FO B  D IS E A S E  C O N T R O L  A N D  P R E V E N T IO N
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The state of knowledge regarding the treatment of patients potentially exposed to 
hazardous substances in the environment is constantly evolving and is often 
uncertain. In this monograph, the Agency for Toxic Substances and Disease 
Registry (ATSDR) has made diligent effort to ensure the accuracy and currency 
of the information presented but makes no claim that the document comprehen­
sively addresses all possible situations related to this substance. This monograph 
is intended as an additional resource for physicians and other health professionals 
in assessing the condition and managing the treatment of patients potentially 
exposed to hazardous substances. It is not, however, a substitute for the 
professional judgment of a health care provider and must be interpreted in light 
of specific information regarding the patient available to such a professional and 
in conjunction with other sources of authority.
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